HR+ BREAST CANCER

Clinical trials for HR+ BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new HR+ BREAST CANCER trials appear

Sign up with your email to follow new studies for HR+ BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 3 Terminated 1

New cancer drug trial halted early

Disease control Terminated

This early-stage study aimed to test the safety and find the right dose of a new drug called BLU-222 for people with advanced solid tumors that have stopped responding to standard treatments. It involved about 50 patients with cancers like breast, ovarian, and gastric cancer. The…

Matched conditions: HR+ BREAST CANCER

Phase: PHASE1 • Sponsor: Blueprint Medicines Corporation • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

HR+ BREAST CANCER

Get alerted when new HR+ BREAST CANCER trials appear

New cancer drug trial halted early